Corvus Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing product candidates that precisely target proteins that are critical to immune cell maturation and function. Its product candidate, soquelitinib, is designed to bind specifically to a protein, interleukin 2 inducible T cell kinase (ITK), involved in T cell activation, T cell receptor signaling and T cell differentiation and function. The other products include Ciforadenant (CPI-444) and Mupadolimab (CPI-006).
Quick Stats
Apr 28, 202655.9
AI Score
HOLD0.78
Volume Ratio
May 14, 2026
Next Earnings
14
+ve Days (30d)
16
-ve Days (30d)
CRVS Stock Summary
Last updated Apr 28, 2026
CRVS is currently trading at $15.62, positioned above its 200-day moving average of $10.35, indicating a long-term uptrend. The stock has a 52-week range of $3.165 to $26.95.
Technical Analysis: The 50-day moving average stands at $15.81, which is above the current price, indicating bearish near-term pressure. The RSI (Relative Strength Index) reads 49.27, suggesting the stock is neutral with balanced momentum.
Money Flow Indicators: The Chaikin Money Flow (20-day) is -0.23, which is negative, suggesting distribution or selling pressure. Our AI-powered investment score rates CRVS at 55.9/100 with a HOLD recommendation.
CRVS (Corvus Pharmaceuticals, Inc.) Indicators
Last updated Apr 28, 2026
| Indicator | Value |
|---|---|
| RSI(14) | 49.27 |
| CMF (20) | -0.23 |
| ROC (10) | 2.426 |
| ADX (14) | 18.133 |
| Indicator | Value |
|---|---|
| MACD (12,26,9) | 0.142 |
| AROONOSC (14) | 35.714 |
| WILLAMS %R (14) | -76.62 |
| MFI (14) | 59.108 |
CRVS Technical Chart
- Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
- SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
- Options OI: Shows max open interest strikes. High OI = significant price levels.
- Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
- Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
- Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
- Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
- Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators
Select indicators above to analyze technical patterns
Indicators will appear below the price chart with perfectly aligned datesVolume Profile Analysis
Horizontal histogram showing volume distribution at each price level with buying/selling pressure
CRVS Price vs Max Options Open Interest
CRVS Max Change In Options Open Interest
CRVS Options - Sort by Max open Interest (near term)
29th April 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
CRVS Daily Out of Money Options - Sort by Max open Interest (near term)
29th April 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
CRVS Daily In the Money Options - Sort by Max open Interest (near term)
29th April 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
CRVS Most Active Options by Volume(near term)
29th April 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | Volume | OI | Change in OI |
Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
Corvus Pharmaceuticals, Inc. is not trading above both 50 Day and 200 Day SMA which is considered Bearish.
CRVS Moving Averages Analysis
Corvus Pharmaceuticals, Inc. has been above 200 day sma 1 times in last 30 days. Last time it was above 200 day sma was on Apr 28, 2026
CRVS (Corvus Pharmaceuticals, Inc.) Simple Moving Averages
Moving Averages are last updated Apr 28, 2026
| Days | MA |
|---|---|
| 10 | 16.11 |
| 20 | 15.5 |
| 30 | 14.98 |
| 50 | 15.81 |
| 100 | 14.3 |
| 200 | 10.35 |
CRVS Fundamental Analysis
| P/E (Forward) | 0 |
| P/E (Trailing) | -- |
| Market Cap ($) | 1.3 billion |
| Earnings/Share ($) | -0.53 |
| Net Proft Margin (%) | 0 |
| Dividend/Share ($) | -- |
| EPS Estimate Current Year ($) | -0.6567 |
| EPS Estimate Next Year ($) | -0.7267 |
| WallStreet Target Price ($) | 33.3333 |
| Most Recent Quarter |
News: Investors speculate on offering price for $CRVS, with some predicting a dump incoming. Despite mixed opinions on Donnie, some are making profits while others warn of a scam. Shorting activity continues as stock price fluctuates.
Updated 2026-01-21 17:00:01